phacidin has been researched along with N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide in 1 studies
| Studies (phacidin) | Trials (phacidin) | Recent Studies (post-2010) (phacidin) | Studies (N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide) | Trials (N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide) | Recent Studies (post-2010) (N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 6 | 0 | 1 |
| Protein | Taxonomy | phacidin (IC50) | N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide (IC50) |
|---|---|---|---|
| Estrogen receptor 1 | Homo sapiens (human) | 17.8949 | |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | 7.508 | |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 6.739 | |
| nuclear receptor subfamily 4 group A member 1 isoform 1 | Homo sapiens (human) | 34.624 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorjsuren, D; Egli, M; Eoff, RL; Jadhav, A; Lloyd, RS; Maloney, DJ; Simeonov, A; Yamanaka, K | 1 |
1 other study(ies) available for phacidin and N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide
| Article | Year |
|---|---|
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Topics: Acrolein; Benzimidazoles; Biphenyl Compounds; Cell Line, Transformed; Cell Survival; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Nucleic Acid Synthesis Inhibitors; Small Molecule Libraries; Terpenes; Tetrazoles; Ultraviolet Rays | 2012 |